Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: Frequent loss of 19p 13.3 and gain of 19q13. 1 - 13.2

Genes Chromosomes and Cancer

Volumn 21, Issue 1, 1998, Pages 8-16

  Höglund, Mattias ^a   Gorunova, Ludmila ^b   Andrén Sandberg, Åke ^b   Dawiskiba, Sigmund ^b   Mitelman, Felix ^b   Johansson, Bertil ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL;

AGED; CARCINOMA; CYTOGENETICS; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0040061124     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199801)21:1<8::AID-GCC3>3.0.CO;2-5     Document Type: Article

References (34)

1. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549-554.
2. Ashworth LK, Batzer MA, Brandriff BF, Branscomb E, de Jong P, Garcia E, Garnes JA, Gordon LA, Lamerdin JE, Lennon G, Mohrenweiser HW, Olsen AS, Slezak T, Carrano AV (1995) An integrated metric physical map of human chromosome 19. Nat Genet 11:422-427.
3. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Andrén-Sandberg Å, Mitelman F, Heim S (1993) Karyotypic abnormalities in tumours of the pancreas. Br J Cancer 67:1106-1112.
4. Bartsch D, Shevlin DW, Tung WS, Kisker O, Wells SA Jr, Goodfellow PJ (1995) Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas. Genes Chromosomes Cancer 14:189-195.
5. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichli PN, Testa JR (1992) AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA 89:9267-9271.
6. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR (1996) Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93:3636-3641.
7. Choong PFM, Mandahl N, Mertens F, Willén H, Alvegård T, Kreicbergs A, Mitelman F, Rydholm A (1996) 19p+ marker chromosome correlates with relapse in malignant fibrous histiocytoma. Genes Chromosomes Cancer 16:88-93.
8. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 51:759-767.
9. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE (1996) Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56:5360-5364.
10. Gordon LA, Bergman A, Christensen M, Danganan L, Lee DA, Ashworth LK, Nelson DO, Olsen AS, Mohrenweiser HW, Carrano AV, Brandriff BF (1995) A 30-Mb metric fluorescence in situ hybridization map of human chromosome 19q. Genomics 30:187-192.
11. Gorunova L, Johansson B, Dawiskiba S, Andrén-Sandberg Å, Jin Y, Mandahl N, Heim S, Mitelman F (1995) Massive cytogenetic heterogeneity in a pancreatic carcinoma: Fifty-four karyotypically unrelated clones. Genes Chromosomes Cancer 14:259-266.
12. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F, Yeo CJ (1994) Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer 9:93-100.
13. Griffin CA, Hruban RH, Morsberger LA, Ellingham T, Long PP, Jaffee EM, Hauda KM, Bohlander SK, Yeo CJ (1995) Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res 55:2394-2399.
14. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55:4670-4675.
15. Hahn SA, Hoque ATMS, Moskaluk CA, da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE (1996a) Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 56:490-494.
16. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996b) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
17. Heim S, Mitelman F (1995) Cancer Cytogenetics, 2nd ed. New York: Wiley-Liss.
18. Höglund M, Johansson B, Pedersen-Bjergaard J, Marynen P, Mitelman F (1996) Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 87:324-330.
19. Höhne MW, Halatsch M-E, Kahl GF, Weinel RJ (1992) Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 52:2616-2619.
20. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL (1993) K-ras oncogene activation in adenocarcinoma of the pancreas: A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specifie oligonucleotide hybridisation. Am J Pathol 143:545-554.
21. Johansson B, Bardi G, Heim S, Mandahl N, Mertens F, Bak-Jensen E, André-Sandberg Å, Mitelman F (1992) Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer 69:1674-1681.
22. Johansson B, Bardi G, Pandis N, Gorunova L, Bäckman PL, Mandahl N, Dawiskiba S, Andrén-Sandberg Å, Heim S, Mitelman F (1994) Karyotypic pattern of pancreatic adenocarcinomas correlates with survival and tumour grade. Int J Cancer 58:8-13.
23. Johansson B, Mertens K, Mitelman F (1996) Primary vs. secondary neoplasia-associated chromosomal abnormalities-balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 16:155-163.
24. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-385.
25. Koff A, Cross F, Fischer A, Schumacher J, Leguellec K, Philippe M, Roberts JM (1991) Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66:1217-1228.
26. Maniatis T, Fritsch EF, Sambrook J (1982) Molecular Cloning: A Laboratory Manual, 1st Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
27. Mitelman F (1994) Catalog of Chromosome Aberrations in Cancer, 5th Ed. New York: Wiley-Liss.
28. Murr MM, Sarr MG, Oishi AJ, van Heerden JA (1994) Pancreatic cancer. CA Cancer J Clin 44:304-318.
29. Pejovic T, Heim S, Mandahl N, Elmfors B, Flodérus UM, Furgyik S, Helm G, Willén H, Mitelman F (1989) Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas. Genes Chromosomes Cancer 1:167-171.
30. Rodriguez E, Sreekantaiah C, Chaganti RSK (1994) Genetic changes in epithelial solid neoplasia. Cancer Res 54:3398-3406.
31. Ruggeri B, Zhang S-Y, Caamano J, DiRado M, Flynn SD, Klein-Szanto AJP (1992) Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene 7:1503-1511.
32. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ, Kern SE (1994) Allelotype of pancreatic adenocarcinoma. Cancer Res 54:2761-2764.
33. Thompson FH, Nelson MA, Trent JM, Guan XY, Liu Y, Yang JM, Emerson J, Adair L, Wymer J, Balfour C, Massey K, Weinstein R, Alberts DS, Taetl R (1996) Amplification of 19q13.1-19q13.2 sequences in ovarian cancers. Cancer Genet Cytogenet 87:55-62.
34. Warshaw AL, Fernández-del Castillo C (1992) Pancreatic carcinoma. N Kngl J Med 326:455-465.